1 / 13

Cataract Surgery Stephen G. Slade MD, FACS

Cataract Surgery Stephen G. Slade MD, FACS. Financial Disclosure. Alcon, AMO, B&L Consultant, Clarity, NuLens, RVO, Technolas. This presentation represents the speaker’s professional experience. US Cataract Market. 18,900,000 Global Procedures 2010 3,261,000 US Procedures

mina
Télécharger la présentation

Cataract Surgery Stephen G. Slade MD, FACS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cataract Surgery Stephen G. Slade MD, FACS

  2. Financial Disclosure Alcon, AMO, B&L Consultant, Clarity, NuLens, RVO, Technolas This presentation represents the speaker’s professional experience.

  3. US Cataract Market • 18,900,000 Global Procedures 2010 • 3,261,000 US Procedures • 900 million US Equipment and Packs • 85 million US Presbyopes • 72% with 0.5 D or greater Astigmatism Medicare, Marketscope

  4. US Eye Surgeons • Cataract Only Surgeons 4,990 • Refractive Only 1,350 • Cataract / Refractive Surgeons 2,260 • Total 8,600 Marketscope Surveys

  5. Is Cataract Surgery Effective Enough? Only 6.4% penetration rate Visual Outcomes less than LASIK No safety improvement Surgeon confidence lower 100% 85% 75% 20/40 or better 20/40 and J3 or better 20/20 or better 35% * Adapted from FDA clinical data for Crystalens and Wavelight Trials Wavelight FDA Trial, Myopia Astigmatism. Crystalens AT 45 FDA 20/25 and J1 or better

  6. Medicare vs Private Pay 22% Non Medicare 12% Medicare Managed Care 66% Medicare Source: 2007 Medicare Data

  7. US Surgeries by Ownership Corporate Owned ASC 17.1% Hospital Owned ASC 22.3% Physician Owned ASC 60.6% Source MarketScope

  8. Cataract Surgeons by Volume 600-1199 17.9% 1200-1599 2.6% 200-599 47.2% >1600 1.5% <100 13.3% 100-199 17.5% Source MarketScope

  9. What percentage of your eligible patients elected to receive premium IOLs in the past 3 months?A. 0% to 10%B. 11% to 20%C. 21% to 30%D. Greater than 30% Question #1

  10. What premium lens is your lens of choice for your patients?A. Crystalens 5.0B. Crystalens HDC. Crystalens AOD. Acrysof ReSTOR IOL (+3.0D)E. Tecnis MFF. AcrySof ToricG. OtherH. None, I prefer monofocal IOLs Question #2

  11. What is the most important distance to be on target for in the Premium Channel?A. DistanceB. IntermediateC. Near Question #3

  12. If it was your own eye, which lens would you select?A. AcrySof Toric IOLB. Tecnis Multifocal IOLC. Crystalens 5.0D. Crystalens HDE. Crystalens AOF. AcrySof ReSTOR IOL (+3.0) Question #4

More Related